CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea flag South Korea · Delayed Price · Currency is KRW
569.00
+3.00 (0.53%)
Sep 18, 2026, 3:30 PM KST

CMG Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Cash & Equivalents
11,5126,1232,5881,2434,45618,571
Short-Term Investments
6,29120,37974,20667,58573,35739,000
Trading Asset Securities
-----62,003
Cash & Short-Term Investments
17,80326,50276,79468,82777,813119,574
Cash Growth
-71.70%-65.49%11.58%-11.55%-34.92%119.54%
Accounts Receivable
36,94234,71531,31223,32021,33020,291
Other Receivables
986.11637.151,174929.561,143869.89
Receivables
37,93635,36032,48624,25034,54221,161
Inventory
26,52429,54223,78820,57021,2709,049
Prepaid Expenses
112.532,752141.95150.35143.371.04
Other Current Assets
921.871,0221,6491,9401,301729.16
Total Current Assets
83,29895,179134,859115,737135,070150,584
Property, Plant & Equipment
133,199114,99477,97750,71137,47224,119
Long-Term Investments
61,73655,52546,46352,56522,9964,003
Goodwill
2,2742,2742,2742,274--
Other Intangible Assets
3,2173,4372,9083,6753,1051,339
Long-Term Deferred Tax Assets
4,8555,5083,3152,9732,6032,006
Long-Term Deferred Charges
13,48412,76116,37213,62711,2829,736
Other Long-Term Assets
495.01477.9291.94456.59621.92455.44
Total Assets
320,066305,962303,437242,098213,260192,243

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Accounts Payable
7,6769,58112,0139,19711,2454,328
Accrued Expenses
1,9391,8263,1983,2042,9172,054
Short-Term Debt
25,00546,72144,068880--
Current Portion of Long-Term Debt
025,0000---
Current Portion of Leases
134.27142.68221.4206.16356.41129.64
Current Income Taxes Payable
-161.54--99.45-
Other Current Liabilities
36,18520,22415,14511,0427,2852,794
Total Current Liabilities
70,939103,65674,64524,52921,9039,306
Long-Term Debt
43,500-35,43624,7016,000-
Long-Term Leases
61.79144.85240.26332.07356.43156.76
Pension & Post-Retirement Benefits
1,109467.921,091753.79-1,057
Other Long-Term Liabilities
155.35138.052,4831,55048.381,565
Total Liabilities
115,765104,407113,89551,86628,30712,085

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Common Stock
74,06273,92169,44669,44669,44669,446
Additional Paid-In Capital
123,002122,556104,889104,641104,641104,812
Retained Earnings
6,7954,64413,89414,2199,0005,055
Comprehensive Income & Other
442.75433.391,3131,9261,866845.23
Shareholders' Equity
204,301201,555189,542190,233184,953180,158
Total Liabilities & Equity
320,066305,962303,437242,098213,260192,243

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Total Debt
68,70172,00879,96526,1196,713286.39
Net Cash (Debt)
-50,898-45,506-3,17142,70871,100119,288
Net Cash Growth
----39.93%-40.40%119.02%
Net Cash Per Share
-344.36-315.51-5.88307.49511.91981.40
Filing Date Shares Outstanding
148.12147.84138.89138.89138.89138.89
Total Common Shares Outstanding
148.12147.84138.89138.89138.89138.89
Working Capital
12,359-8,47760,21491,208113,167141,278
Book Value Per Share
1379.261363.311364.671369.641331.631297.11
Tangible Book Value
198,811195,844184,360184,284181,848178,820
Tangible Book Value Per Share
1342.201324.691327.361326.811309.281287.47
Land
19,57519,57519,5743,9852,7092,709
Buildings
8,12712,68012,31211,00410,74110,741
Machinery
3,36318,93719,59218,42116,93414,678
Construction In Progress
101,38582,46644,61734,09422,5797,511